Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism

Immunotherapy based on checkpoint inhibitors is providing substantial clinical benefit, but only to a minority of cancer patients. The current priority is to understand why the majority of patients fail to respond. Besides T-cell dysfunction, T-cell apoptosis was reported in several recent studies a...

Полное описание

Библиографические подробности
Главные авторы:	Zhu, J, Petit, P, Van Den Eynde, B
Формат:	Journal article
Язык:	English
Опубликовано:	Springer Berlin Heidelberg 2018

Схожие документы

Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
по: Zhu, J, и др.
Опубликовано: (2017)

Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
по: Jeroen F. Vermeulen, и др.
Опубликовано: (2018-03-01)

Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
по: Yunyan Dai, и др.
Опубликовано: (2025-01-01)

Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytes
по: Joel Kidman, и др.
Опубликовано: (2024-12-01)

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
по: I.A.J. van Duin, и др.
Опубликовано: (2024-12-01)

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
по: Finisguerra, V, и др.
Опубликовано: (2023)

Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment
по: Iman M. Talaat, и др.
Опубликовано: (2022-08-01)

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
по: Benoit J Van den Eynde, и др.
Опубликовано: (2023-05-01)

Expression of immune checkpoints (PD-L1 and IDO) and tumour-infiltrating lymphocytes in breast cancer
по: Noura Alkhayyal, и др.
Опубликовано: (2022-09-01)

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade
по: Elly Marcq, и др.
Опубликовано: (2024-09-01)

Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study
по: Yu-Chen Li, и др.
Опубликовано: (2020-01-01)

Tryptophan-degrading enzymes in tumoral immune resistance
по: Nicolas van Baren, и др.
Опубликовано: (2016-11-01)

Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome
по: Brian Z Ring, и др.
Опубликовано: (2025-01-01)

Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study
по: Chiara Cremolini, и др.
Опубликовано: (2023-04-01)

Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
по: Priyakshi Kalita-de Croft, и др.
Опубликовано: (2021-05-01)

POLE and Mismatch Repair Status, Checkpoint Proteins and Tumor-Infiltrating Lymphocytes in Combination, and Tumor Differentiation: Identify Endometrial Cancers for Immunotherapy
по: Dandan Dong, и др.
Опубликовано: (2021-03-01)

WAYS TO ENHANCE LYMPHOCYTE TRAFFICKING INTO TUMORS AND FITNESS OF TUMOR INFILTRATING LYMPHOCYTES
по: Matteo eBellone, и др.
Опубликовано: (2013-09-01)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
по: Oliver Kepp, и др.
Опубликовано: (2023-12-01)

The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
по: Dong Liu, и др.
Опубликовано: (2022-04-01)

Role of tumor-infiltrating lymphocytes in melanoma
по: Yasemin Benderli Cihan
Опубликовано: (2019-01-01)

Influence of Tumor Immune Infiltration on Immune Checkpoint Inhibitor Therapeutic Efficacy: A Computational Retrospective Study
по: Rong Liu, и др.
Опубликовано: (2021-06-01)

PD-L1 Expression and Tumor Infiltrating Lymphocytes in Neurofibromatosis Type 1-Related Benign Tumors and Malignant Peripheral Nerve Sheath Tumors: An Implication for Immune Checkpoint Inhibition Therapy
по: Jin LIU, и др.
Опубликовано: (2021-06-01)

177 Treatment outcomes with unselected autologous tumor infiltrating lymphocytes in patients with checkpoint inhibition–refractory advanced cutaneous melanoma
по: Natalia Kirillova, и др.
Опубликовано: (2021-11-01)

Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option
по: Maartje W. Rohaan, и др.
Опубликовано: (2018-10-01)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
по: McAuliffe, J, и др.
Опубликовано: (2021)

Marsdenia tenacissima enhances immune response of tumor infiltrating T lymphocytes to colorectal cancer
по: Ben Yi, и др.
Опубликовано: (2023-08-01)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
по: Paula García-Teijido, и др.
Опубликовано: (2016-04-01)

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
по: Paula García-Teijido, и др.
Опубликовано: (2016-01-01)

Immunity and cancer: role of tumor-infiltrating lymphocytes in triple-negative breast cancer
по: Ana Tečić-Vuger, и др.
Опубликовано: (2021-01-01)

T lymphocyte-targeted immune checkpoint modulation in glioma
по: Mark Gilbert, и др.
Опубликовано: (2020-05-01)

Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
по: Shuhang Wang, и др.
Опубликовано: (2021-06-01)

1306 Negative selection of ligand-receptor interactions mediating lymphocyte infiltration confers melanoma resistance to immune checkpoint blockade therapy by turning hot tumors to cold
по: Binbin Wang, и др.
Опубликовано: (2023-11-01)

Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
по: Cristina Valero, и др.
Опубликовано: (2021-02-01)

MTHFR act as a potential cancer biomarker in immune checkpoints blockades, heterogeneity, tumor microenvironment and immune infiltration
по: Jianheng Peng, и др.
Опубликовано: (2023-06-01)

Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
по: Akira Kazama, и др.
Опубликовано: (2022-11-01)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
по: Cor J. Ravensbergen, и др.
Опубликовано: (2021-10-01)

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
по: Salman M. Toor, и др.
Опубликовано: (2019-12-01)

Arid5a: A missing link between EMT and tumoral immune resistance
по: Van den Eynde, BJ
Опубликовано: (2021)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
по: Federica Cappuccini, и др.
Опубликовано: (2021-09-01)

Advances and prospects in tumor infiltrating lymphocyte therapy
по: Xu Qiu, и др.
Опубликовано: (2024-11-01)